Corporate Actions & Capital Structure › Sub-category
Conversion / Redemption
5 articles
Capital structure adjustments are becoming more prevalent across Indian companies, reflecting a strategic shift towards strengthening balance sheets and aligning with growth initiatives. PI Industries notably approved the conversion of a substantial Rs 70,000 crore in OFCDs within its subsidiary, PI Health Sciences, into equity, reinforcing its ownership and financial position. Simultaneously, companies like Cranex Limited and Bilcare are executing warrant and loan conversions, while Mangalam Global anticipates a similar move, demonstrating a broader trend of leveraging existing instruments to bolster equity bases. These actions, while varying in scale, suggest a proactive approach to optimizing capital structures and potentially unlocking future investment opportunities.
Indo Thai Securities Allots 1.72M Shares via Warrant Conversion
Indo Thai Securities' committee approved conversion of 172,000 warrants into 1.72 million equity shares at ₹37.5 per share.
The conversion raised ₹6.45 crore from four non-promoter investors, increasi
Poojawestern Metaliks Board Meeting for Fundraising
Poojawestern Metaliks schedules July 16, 2026 board meeting to consider fundraising via equity or convertible instruments.
Board to evaluate proposal for converting promoter loans into company equity
Everest Organics Allots 2.63L Shares to Promoter
Everest Organics allotted 263,157 equity shares to its Managing Director & Promoter upon conversion of warrants at ₹152 per share.
The allotment, approved by board resolution on July 11, 2026, follows
Shah Metacorp Board Approves Mona Shah Warrant Conversion
Shah Metacorp intimates exchanges of a board meeting scheduled for July 16, 2026.
The board will consider allotting equity shares to Mona Viral Shah from convertible warrants.
The disclosure is a mand
Bilcare Converts 265k Warrants in Caprihans India
Bilcare Limited, the promoter of Caprihans India, converted 265,000 warrants into equity shares on June 2, 2026, as the fourth tranche of conversion.
The conversion increased Bilcare's equity stake in